Barely three months after the government cracked down on overpriced stents, the state Food and Drug Administration (FDA) has found three city hospitals guilty of not only reusing medical devices meant for single use, but also charging multiple patients for the same.
Fortis Hospital in Mulund, Hiranandani Hospital in Vashi, which is managed by the Fortis group, and BSES Hospital in Andheri have been issued show-cause notices for violating the Drug and Cosmetics Act. “Based on information of recycling and reuse of medical devices on multiple patients, the FDA 's intelligence branch carried out an investigation between March 29 and April 1,“ said FDA commissioner Harshdeep Kamble. “These hospitals reused devices without taking consent or without giving prior information to patients,“ he added.
The FDA team checked on drug notified medical devices such as guiding catheters and balloon catheters that are used for angioplasty -performed to remove blockages in arteries. The raids also exposed the huge gap -up to four times -between the device's purchase price for hospitals and their MRP (maximum retail price).